✦ LIBER ✦

Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndrome

✍ Scribed by Hussam Ghoti; Eitan Fibach; Mark Westerman; Olbina Gordana; Tomas Ganz; Eliezer A. Rachmilewitz

Book ID: 108677169
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 150 KB
Volume: 153
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2011.08587.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Deferasirox induces regression of iron o

Deferasirox induces regression of iron overload in patients with myelodysplastic syndromes

✍ F. Wimazal; T. Nösslinger; C. Baumgartner; W. R. Sperr; M. Pfeilstöcker; P. Vale 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Red blood cell transfusions and iron ove

Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes

✍ Elias Jabbour; Hagop M. Kantarjian; Charles Koller; Ali Taher 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views

## Abstract ## BACKGROUND Approximately 15,000 new cases of myelodysplastic syndromes (MDS) are expected in the United States each year. ## METHODS The mainstay for the management of myelodysplastic syndromes (MDS) is supportive therapy with red blood cell (RBC) transfusions to improve the patie

Treatment of transfusional iron overload

Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices

✍ Anastasios Raptis; Mei Sheng Duh; Si-Tien Wang; Ellison Dial; Ilias Fanourgiakis 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 176 KB